Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Author: sugaradmin

1607-P: Multiomic Analyses of GLP-1/GIP/GCGR Triagonism Highlights the Role of Hepatic Lipid Metabolism during Weight Loss in Obese Mice

July 20, 2025 by sugaradmin

Introduction and Objective: GCGR agonism stimulates energy expenditure (EE) and weight loss in rodents. Moreover, when combined with the antidiabetic actions of incretins (GLP1, GIP), GCGR-agonists lack hyperglycemic side effects. We also identified anti-obesity effects of GCGR agonism for 50d after treatment cessation. Thus, we hypothesized that a GLP-1/GIP/GCGR triple agonist (GGG) will increase EE […]

Read More
DiabetesLeave a Comment on 1607-P: Multiomic Analyses of GLP-1/GIP/GCGR Triagonism Highlights the Role of Hepatic Lipid Metabolism during Weight Loss in Obese Mice

688-P: Personality as a Predictor of Self-Management, Diabetes Distress, and Glycemic Control in Adults with Type 1 Diabetes (T1D)

July 20, 2025 by sugaradmin

Introduction and Objective: Personality may influence key glycemic, behavioral, and emotional outcomes in people with T1D. We investigated Five-Factor Model (FFM) personality traits as predictors of self-management (SM), diabetes distress, and continuous glucose monitoring (CGM) metrics among 187 diverse adults with T1D.Methods: Participants wore CGM and rated their SM (each evening on a 0-100 scale) […]

Read More
DiabetesLeave a Comment on 688-P: Personality as a Predictor of Self-Management, Diabetes Distress, and Glycemic Control in Adults with Type 1 Diabetes (T1D)

1606-P: Impact of Insulin Resistance and BMI on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in Nondiabetic Individuals

July 20, 2025 by sugaradmin

Introduction and Objective: Insulin resistance (IR) and higher BMI are associated with the development of MASLD. However, their independent association with “at-risk” MASLD (i.e., steatohepatitis with clinically significant fibrosis or stage ≥F2; MASLD≥F2) is unclear. We investigated how IR and obesity interact to impact MASLD severity.Methods: We divided 283 individuals without diabetes into having overweight […]

Read More
DiabetesLeave a Comment on 1606-P: Impact of Insulin Resistance and BMI on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in Nondiabetic Individuals

261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education

July 20, 2025 by sugaradmin

Introduction and Objective: The growing prevalence of diabetes underscores the need for scalable, patient-centric tools to support diabetes self-management and education (DSME). Mitraa, a GPT-based conversational AI model, was developed to provide personalized diabetes care, including guidance on nutrition, medication adherence, glucose monitoring, and lifestyle adjustments. This study validates Mitraa’s effectiveness in delivering accurate, patient-relevant […]

Read More
DiabetesLeave a Comment on 261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education

1605-P: Insulin Resistance Promotes Steatosis and Increases the Risk of Clinically Significant Fibrosis in People with Type 2 Diabetes

July 20, 2025 by sugaradmin

Introduction and Objective: Type 2 diabetes (T2D) is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD) which may lead to clinically significant fibrosis (defined as moderate-to-severe fibrosis stage ≥F2 or “at-risk” MASLD≥F2) and eventually cirrhosis. The role of insulin resistance (IR) in the development of MASLD≥F2 remains unclear. We examined the relationship of IR […]

Read More
DiabetesLeave a Comment on 1605-P: Insulin Resistance Promotes Steatosis and Increases the Risk of Clinically Significant Fibrosis in People with Type 2 Diabetes

35-PUB: A Novel Integrated Risk Stratification Framework for Diabetes Management in Saudi MEDGULF-Insured Patients

July 20, 2025 by sugaradmin

Introduction and Objective: Chronic diseases like diabetes strain healthcare systems among Saudi MEDGULF insured population. Traditional clinical guidelines and advanced AI-driven methods often exist in silos, hindering comprehensive management. This study introduces an Integrated Clinical-AI Stratification Framework that unifies evidence-based clinical protocols with AI models to enhance early detection, individualized risk stratification, and personalized interventions […]

Read More
DiabetesLeave a Comment on 35-PUB: A Novel Integrated Risk Stratification Framework for Diabetes Management in Saudi MEDGULF-Insured Patients

1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance

July 20, 2025 by sugaradmin

Introduction and Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with “at-risk” MASH (steatohepatitis with significant fibrosis stage ≥F2) and cirrhosis. Magnetic resonance (MR) iron-corrected T1 mapping (cT1) allows for improved MASH risk stratification, but whether it may help define their metabolic profile needs further validation.Methods: We measured AST, ALT, HbA1c, insulin, FFA, liver […]

Read More
DiabetesLeave a Comment on 1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance

358-OR: Acute Fatty Acid Elevation Does Not Alter Brain Glucose Uptake in Humans

July 20, 2025 by sugaradmin

Introduction and Objective: Acute elevation of non-esterified fatty acids (NEFA) can induce peripheral insulin resistance and impair glucose uptake in muscle. Rodent studies have shown that elevation of NEFA through a high-fat diet impairs brain glucose uptake, and prior observational studies by our group have reported that higher NEFA levels correlate with lower brain glucose. […]

Read More
DiabetesLeave a Comment on 358-OR: Acute Fatty Acid Elevation Does Not Alter Brain Glucose Uptake in Humans

1603-P: ROCK1 in Hepatic Stellate Cells Regulates Insulin Sensitivity and Communicates with Muscle during Overnutrition

July 20, 2025 by sugaradmin

Introduction and Objective: Hepatic stellate cells (HSCs) play a key role in developing insulin resistance. While Rho-kinase 1 (ROCK1) activation in hepatocytes promotes obesity-induced insulin resistance, the physiological role of ROCK1 in HSCs remains unclear. This study investigated the importance of ROCK1 in HSCs in the context of obesity-related metabolic dysfunction.Methods: Mice lacking ROCK1 in […]

Read More
DiabetesLeave a Comment on 1603-P: ROCK1 in Hepatic Stellate Cells Regulates Insulin Sensitivity and Communicates with Muscle during Overnutrition

1844-P: Cytokines Function to Mediate an Innate Immune/Endocrine Axis

July 20, 2025 by sugaradmin

Introduction and Objective: It has been suggested that infection may contribute to T1D development via extended exposure of islets to proinflammatory cytokines. Recent evidence, however, suggests that the primary effects of cytokine signaling in islets may be protective through the upregulation of antipathogen and antioxidant genes in β-cells. This study tests the hypothesis that there […]

Read More
DiabetesLeave a Comment on 1844-P: Cytokines Function to Mediate an Innate Immune/Endocrine Axis

Posts navigation

Older posts
Newer posts

Recent Posts

  • New Food Pyramid: What It Recommends Eating
  • Heart Attack: Energy Drinks May Quadruple Risk in Adults Under 35
  • Stroke, Heart Disease: Salt Substitutes May Prevent Millions of Deaths
  • Type 2 Diabetes: 54% Young Adults Enter Remission with Diet, Exercise
  • GLP-1s May Help Lower Diabetes Risk More Effectively Than Metformin

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness